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A ‘‘bidirectional gene pair’’ comprises two adjacent genes whose transcription start sites are neighboring and directed
away from each other. The intervening regulatory region is called a ‘‘bidirectional promoter.’’ These promoters are
often associated with genes that function in DNA repair, with the potential to participate in the development of cancer.
No connection between these gene pairs and cancer has been previously investigated. Using the database of spliced-
expressed sequence tags (ESTs), we identified the most complete collection of human transcripts under the control of
bidirectional promoters. A rigorous screen of the spliced EST data identified new bidirectional promoters, many of
which functioned as alternative promoters or regulated novel transcripts. Additionally, we show a highly significant
enrichment of bidirectional promoters in genes implicated in somatic cancer, including a substantial number of genes
implicated in breast and ovarian cancers. The repeated use of this promoter structure in the human genome suggests it
could regulate co-expression patterns among groups of genes. Using microarray expression data from 79 human
tissues, we verify regulatory networks among genes controlled by bidirectional promoters. Subsets of these promoters
contain similar combinations of transcription factor binding sites, including evolutionarily conserved ETS factor
binding sites in ERBB2, FANCD2, and BRCA2. Interpreting the regulation of genes involved in co-expression networks,
especially those involved in cancer, will be an important step toward defining molecular events that may contribute to
disease.
Citation: Yang MQ, Koehly LM, Elnitski LL (2007) Comprehensive annotation of bidirectional promoters identifies co-regulation among breast and ovarian cancer genes. PLoS
Comput Biol 3(4): e72. doi:10.1371/journal.pcbi.0030072
Introduction
Bidirectional gene pairs are deﬁned as two genes arranged
head-to-head (adjacent 59 ends) on opposite strands of DNA
and within 1,000 bp of one another [1]. The deﬁnition of
1,000 bp is supported by analyses of Trinklein et al. [2], which
show an enrichment of genes whose 59 ends are on opposite
strands and within 1,000 bp and no enrichment of genes with
59 ends on the same strand at this distance. The sequences
between the transcription start sites of bidirectional gene
pairs are known as bidirectional promoters, and they
inﬂuence expression of both adjacent genes. Bidirectional
promoters represent a regulatory construction that is utilized
repeatedly in the human genome, with 1,352 known examples
[2].
Despite substantial interest in these promoters [1–3], the
biological signiﬁcance of this regulatory architecture is not
well-established. The bidirectional arrangement is conserved
among species, suggesting that it is functionally important [2].
Furthermore, a strand-speciﬁc pattern of the nucleotides in
these promoters [3] could play a role in binding regulatory
proteins. For instance, SP1-binding sites have been suggested
as key regulators of CpG island promoters [4]. If groups of
bidirectional promoters are similarly regulated, then dis-
tantly located genes under the control of these promoters
should show common expression patterns. Additional regu-
latory factors must also be involved, because genes that form
a bidirectional pair are not always expressed together.
Experimental studies show that within a pair, genes can be
expressed in a mutually exclusive manner [2]. How the
intervening promoter sequence preferentially activates one
gene versus another is currently unknown.
The categories of genes regulated by these promoters imply
that specialized transcription factor binding sites could
regulate expression of these genes. For instance, bidirectional
promoters regulate DNA repair genes [1]. DNA repair genes
frequently play a role in cancer that is elicited through
mutations in their coding sequences. However, another
plausible scenario toward the development of cancer comes
from the misregulation of bidirectional promoters, especially
if they contain common transcription factor binding sites.
These sites would be candidates to explain a general
mechanism in which regulatory disruptions at bidirectional
promoters could play a pivotal role in cancer.
We developed a new algorithm to comprehensively map
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expressed sequence tags (ESTs). The extended set of bidirec-
tional promoters elucidates relationships among genes
regulated by bidirectional promoters through co-expression
networks. We show evidence that a subset of these promoters,
which regulate genes implicated in breast and ovarian
cancers, contain transcription factor binding sites in com-
mon.
Results
Mapping and Validation of Bidirectional Promoters
Although ESTs frequently represent truncated forms of
full-length mRNAs, large EST collections can provide robust
evidence of uncharacterized bidirectional promoters through
a combination of features. For instance, the UCSC (University
of California Santa Cruz) Human Genome Browser (http://
www.genome.ucsc.edu) annotates the direction of transcrip-
tion for each EST. Also, EST data contains thousands of
transcripts captured by oligo-capping techniques, providing
enrichment in the 59 sequences of genes [5]. Given this
information, we hypothesized that neighboring, spliced ESTs,
which are transcribed in opposite directions and initiate
within 1 kb of one another, are unlikely to represent
disconnected pieces of the same transcript, and thereby
represent either a bidirectional or a cis-antisense overlapping
gene pair.
Our initial screen to identify bidirectional promoters
partitioned the output according to its presence within
annotation tracks of the UCSC Genome Browser. Because the
spliced ESTs are the most complicated dataset, priority was
given to promoters identiﬁed in more highly curated datasets,
such as Known Genes and GenBank mRNA, over the spliced
human ESTs [6]. Our dataset was compared with the
previously published collection of bidirectional promoters
[2], conﬁrming 99.6% of that collection and contributing an
additional 300% (Figure 1). The majority of newly identiﬁed
bidirectional promoters came from the GenBank mRNA
track (2,862) and from the spliced EST data (1,785). Overall,
the spliced ESTs and mRNA identiﬁed nearly equivalent
amounts of these promoters (3,529 or 3,855, respectively), but
priority was given to the mRNA annotations for direct
comparison to the previous dataset.
Overall, we found strong evidence for 5,653 bidirectional
promoters in the human genome. All promoters deﬁned only
by EST data were scrutinized by comparison with GenBank
mRNA and UCSC Known Genes to detect complementary
support for the direction of transcription. In this way, we
determined that 1,100 of the EST transcripts ﬂanking a
bidirectional promoter are novel transcripts, overlapping
nothing in either reference track. Another 974 overlap an
mRNA or Known Gene, and extend the 59 position of that
reference gene by more than 100 bp. Some of these extension
events add a full 59 UTR to the reference gene and cover
extreme distances to join an upstream alternative promoter.
For example, the bidirectional promoters identiﬁed upstream
of ERBB2 (HER2/NEU) or novel gene AK094318 lie 10 kb and
140 kb away, respectively, from additional downstream
promoters (unpublished data).
To validate the EST gene pairs using biological evidence, all
intervening regions were examined for two features known to
associate with promoters: TAF250 binding (or TAF1 [7]) and
CpG islands. Greater than 50% of the bidirectional pro-
moters identiﬁed solely from the spliced EST data have
TAF250 present at both transcription start sites (and 70%
have at least 1), and more than 90% have CpG islands. Thus,
the bidirectional promoters identiﬁed using the spliced EST
data can represent biologically active promoters. Further-
more, to verify biological activity of these predicted bidirec-
tional promoters, each was compared with existing 59 capped
transcription data (known as CAGE) [8]. This independent
experimental data conﬁrmed the expression of pairs of
ﬂanking transcripts for 91%, 58%, and 65% of the promoters
in the Known Genes, mRNA, and EST datasets, respectively
(Figure S1).
Significant Overrepresentation of Bidirectional Promoters
Associated with Cancer-Related Genes
The strong enrichment of bidirectional promoters associ-
ated with DNA repair genes [1] implies a possible link
between this regulatory mechanism and genes participating
in cancer pathways. Therefore, we examined DNA main-
tenance, metabolism, and repair genes from the COSMIC
database (Catalogue of Somatic Mutations in Cancer; [9]) for
an association with bidirectional promoters. Of 302 genes
implicated in somatic cancer, 45% had bidirectional pro-
moters. The association is statistically signiﬁcant with a p-
value of  10e-6. In comparison, when sampled randomly
from the genome, only 31% of human genes were associated
with a bidirectional promoter. Furthermore, without our EST
and mRNA analyses, only 12% of the genes on the COSMIC
list could be identiﬁed as having a bidirectional promoter.
Other lists of somatic cancer genes were examined,
including breast and colon cancer genes [10]. A signiﬁcant
enrichment of bidirectional promoters was found for somatic
breast cancer genes (with a p-value of 0.01), but not somatic
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Author Summary
Promoters are regulatory regions that control transcription of genes.
A special class of promoters, known as bidirectional promoters,
regulates expression of two genes instead of one. These promoters
are situated between two adjacent genes whose transcription start
sites are physically within 1,000 bp and oriented in opposite
directions. Bidirectional promoters are found repeatedly in the
genome, suggesting an important biological significance for this
regulatory configuration. We developed an algorithm to map
bidirectional promoters using data from a comprehensive list of
transcribed sequences known as expressed sequence tags, or ESTs.
This approach improved the number of previously characterized
bidirectional promoters by 300%. Included in the new data are
bidirectional promoters that regulate expression of genes impli-
cated in somatic cancers. For instance, ten well-recognized genes
implicated in breast and ovarian cancers were identified as having
bidirectional promoters. Three of the genes are further related by
having duplicate copies of the same binding site for a transcription
factor within their bidirectional promoters. These binding sites are
conserved among species, providing greater evidence that they are
functionally important. This example, in which similar regulatory
structures are used to control genes involved in cancer, illustrates
how data can be mined from the comprehensive set of bidirectional
promoters. Within this manuscript, we show statistical evidence that
many cancer genes are regulated by bidirectional promoters. These
promoters will be a valuable dataset for studying the role of gene
regulation in tumor development.
Systematic Mapping of Bidirectional Promoterscolon cancer genes. These data conﬁrm an association
between bidirectional promoters and somatic cancer genes,
and indicate that the type of cancer is relevant.
We further examined bidirectional promoters associated
with genes implicated in uterine and ovarian cancers. For
instance, 16 genes have been implicated in Type I and II
endometrial (uterine) cancers ([11] and references therein),
and we found that eight of them have bidirectional
promoters (Table S1). Although a comprehensive list of all
genes implicated in somatic ovarian cancer is not available, a
brief scan identiﬁed ten genes associated with mutations or
mis-regulation in ovarian (and breast) cancer that have
bidirectional promoters (BRCA1, FANCA, BARD1, FANCF,
TP53, BRCA2, CHEK2, ERBB2, FANCB, and FANCD2; Table 1).
This is the ﬁrst report of bidirectional promoters for all of
these genes except BRCA1 [12] and for these cancer-related
genes as a group. Bidirectional promoters for several of the
genes (for example, BRCA2) were identiﬁed solely from the
spliced EST data. Although the partner to BRCA2 is not a
well-recognized gene, it was originally identiﬁed through
rigorous screening by RT-PCR and sequence conservation to
validate its presence in the cell [13].
Figure 1. Identification of Bidirectional Promoters
The diagram depicts how bidirectional promoters were identified from the UCSC Human Genome Browser annotations, including Known Genes, mRNA,
and spliced ESTs. The number of previously identified bidirectional promoters for each category is marked with an asterisk (*) for comparison.
Promoters identified from more than one source were counted only once. Priority was given to promoters identified from Known Genes followed by
GenBank mRNA, and then spliced ESTs.
doi:10.1371/journal.pcbi.0030072.g001












TAF250 at TSSs CpG Islands at TSSs
BARD1 DA865307 EST EST only No evidence Both Across/first exon of both
BRCA1 NBR2 PC, EST  81 Yes [28] Both Inside NBR2
BRCA2 DR731263 EST EST only Yes [29] Both First exon of BRCA2
CHK2 HSC20 PC, EST  32 Yes [30] Both First exon of Both
HER2/ERBB2 PERLD1 PC, EST  60 Yes [31] Both First exon of Both
TP53 AK001247 PC, EST  491 Yes [32] Both Between/first exon of AK001247
FANCA SPIRE2 EST  10,418 No evidence None First exon of both
FANCB MOSPD2 PC, EST 0 No evidence None Across/first exon of both
FANCD2 BC043599 PC, EST  64 No evidence Both Across/first exon of both
FANCF GAS2 EST  42,706 Yes [29] Both Across/first exon of both
Annotation resources: PC, protein coding gene in the UCSC Human Genome Browser; EST, spliced EST from the GenBank EST database.
aThe decrease in promoter distance by ESTs (bp) represents the difference in promoter length detected using ESTs versus the nonEST annotations.
doi:10.1371/journal.pcbi.0030072.t001
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Systematic Mapping of Bidirectional PromotersRelationships among Genes Regulated by Bidirectional
Promoters
Many of the somatic ovarian cancer genes function in DNA
surveillance and repair. Although none of these ten genes
ﬂank the same bidirectional promoter, several of them
interact in multisubunit complexes implicated in breast or
ovarian cancer, suggesting a large network of genes regulated
to achieve coordinated functions. To address if bidirectional
promoters are limited to a particular protein function,
structural domain, or expression pattern, the ovarian cancer
genes were clustered with other genes in the genome.
Clustering was based on: (1) functional similarity—i.e., using
a classiﬁcation system of the biological function of all
protein-coding genes called gene ontology (GO [14]); (2)
amino-acid sequence and secondary-structure similarity by
comparative alignment through psi-blastP [15]; or (3) similar
expression patterns based on microarray data collected from
79 human tissues [16]. Each type of cluster was assessed for
the ratio of bidirectional promoters. These data were
graphed on the same x-axis, representing the distance
between the transcription start sites for the observed
bidirectional promoters. In this way, all data in the plot
displayed the characteristic asymptotic curve demonstrated
in Trinklein et al. [2], illustrating that the majority of these
start sites were separated by ;300 bp. Furthermore, the ratio
of bidirectional promoters was calculated for the cumulative
number of genes at each distance. Eight of the ten ovarian
cancer genes had a higher ratio of bidirectional promoters in
the co-expression clusters than in the psi-blastP clusters or
GO clusters (Figure 2). This result indicated that the set of
genes regulated by bidirectional promoters extended beyond
a particular function or structure. Therefore, a larger analysis
of co-expression patterns could provide meaningful infor-
mation about co-regulated groups of bidirectional pro-
moters.
Expression Networks Enriched in Bidirectional Promoters
To examine coordinated regulation of bidirectional pro-
moters more thoroughly, we clustered all 16,078 protein-
coding genes into co-expression groups using the 79 tissues in
the Novartis GNF human tissue arrays [16]. Each reference
gene was clustered with its closest 500 expression neighbors.
By analogy, we conﬁrmed that the human beta-globin gene is
most closely co-regulated with the human alpha-globin gene,
whose ﬁnely balanced expression levels are necessary for
physiological homeostasis. Each expression cluster was scored
for the ratio of its 500 genes associated with a bidirectional
promoter. These data were plotted as the number of clusters
versus the ratios, and showed two peaks—containing high or
low ratios of bidirectional promoters relative to the genome
average (Figure 3). The ratios ranged from 0.16 to 0.56.
Extreme enrichment occurred for clusters containing mRNA
Figure 2. Clustering Analysis To Assess Bidirectional Promoters
Clustering methods include microarray expression data (red), GO categories (blue), and psi-blastP alignments (green). The plots show the ratio of
bidirectional promoters calculated for the cumulative number of genes found at each promoter distance. The named breast or ovarian cancer gene
served as the reference gene for each type of cluster. The computational approach used to count the number of bidirectional promoters within each
cluster is described in Methods. GO annotations (blue) were omitted when no data was available.
doi:10.1371/journal.pcbi.0030072.g002
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Systematic Mapping of Bidirectional Promotersprocessing proteins and mitochondrial proteins (with a p-
value of  1e-100 for clustering of these categories compared
with random genome sampling; see Table S2). Extreme
depletion of bidirectional promoters occurred in co-expres-
sion clusters containing sensory perception genes (p-value
 1e-12 from random clustering; see Table S2). Thus, there is
strong evidence of coordinated expression among sets of
genes regulated by bidirectional promoters. This analysis
revealed an additional ovarian cancer gene with a strong
enrichment of bidirectional promoters in its co-expression
cluster, OVCA2 (‘‘candidate tumor suppressor in ovarian
cancer 2’’), a serine hydrolase, which had a ratio of 0.56. In a
smaller comparison, clusters containing DNA repair genes
were skewed toward enrichment for bidirectional promoters,
whereas brain-speciﬁc gene clusters were skewed towards
depletion (Figure 3B and 3C).
Results of the expression-clustering analysis suggested that
bidirectional promoters should not be considered under an
umbrella classiﬁcation for one large regulatory network, nor
should they be divided into thousands of gene pairs. As
illustrated by the ten ovarian cancer genes, the relationships
are intermediate between the two extremes. These genes
showed that one or both members of the pair had signiﬁcant
clustering with other genes regulated by bidirectional
promoters. In two cases, a cancer-related gene clustered less
well than its partner. Despite this clustering, the bidirectional
promoters were able to regulate each ﬂanking gene sepa-
rately, as shown by the decreasing correlation coefﬁcient for
expression between the pairs of genes (Figure 4A and 4B).
These data demonstrated that seven of the ten ovarian cancer
genes ranked in the top quartile of all 16,078 genes for
clustering with other genes regulated by bidirectional
promoters (p-value for enrichment over the genome average
 0.05; Table S3). Additionally, the enrichment was signiﬁcant
compared with a control group of monodirectional pro-
moters in those same clusters [i.e., promoters that regulate
genes arranged in a head-to-tail fashion that fell within 1,000
bp of their neighbor (Figure S2)]. For further comparison,
bidirectional promoters were under-represented in expres-
sion clusters of brain-speciﬁc genes, with an average ratio of
0.23 (Figure S2).
The relationships between the ten ovarian cancer genes
were mapped using multidimensional scaling (MDS) to model
a co-expression network based on the overlap of genes in the
clusters.
Looking within the clusters, we saw seven of the ovarian
cancer genes were co-expressed with the same set of six genes,
and additional genes were shared among smaller numbers of
ovarian cancer genes to suggest an interconnected expression
network. The probability of ﬁnding the same six genes in
seven of the 16,078 clusters was statistically unlikely if their
expression patterns were completely unrelated (less than 1/
10,000; see Methods). Two of the shared genes, MLH1 and
ITGB3BP, have bidirectional promoters; they are known to
function in ovarian or breast cancer, respectively [17–18].
The bipartite graph (showing relationships to and from the
reference gene) resulting from the MDS analysis illustrated
the similarity in co-expression patterns as the distances
between the reference genes (Figure S3). The ten cancer
genes separated into three groups based on similarity of their
co-expression clusters. The groups contained BRCA1, FANCA,
and BARD1; FANCF, TP53, and BRCA2; and ERBB2, FANCB,
Figure 3. Frequency of Bidirectional Promoters
Each of 16,078 genes represented in the microarray data was grouped
with its 500 most-related genes into an expression cohort. The ratio of
bidirectional promoters in each expression cohort was plotted for three
categories: (A) all genes, (B) DNA-repair genes, or (C) brain-specific genes.
doi:10.1371/journal.pcbi.0030072.g003
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Systematic Mapping of Bidirectional Promotersand FANCD2. The groupings suggested that subsets of genes
could have transcription factor binding sites in common.
Shared Transcription Factor Binding Sites
Relationships between these cancer-related genes were
further supported by the presence of shared transcription
factor binding sites. We mapped 741 consensus motifs [19] to
ﬁnd the most frequent occurrences in these bidirectional
promoters. The most common motifs were Sp1, NFAT, EGR-
1, PAX4 (or RXR), and the ETS factor family member, ELK1.
Compared with the set of brain-speciﬁc genes, the ten cancer
genes had a 10-fold larger representation of consensus ETS
factor binding sites. These sites comprised ELK1-binding
sites, plus overlapping recognition sequences for other ETS
factor family members (PEA3 and GABP). Conﬁrming the
hypothesis of a regulatory connection between some of these
genes, tandem conserved binding sites for ELK1 mapped to
the same position in ERBB2 and FANCD2, 50 bp upstream of
the transcription start site (Figure 5). A single conserved site
containing this same DNA sequence was found at nearly the
same distance upstream of BRCA2. BRCA1 also had tandem
sequences for the core of ETS factor binding sites (GGAA)
near this position (unpublished data). Additionally, ETS
factor binding sites were present as a trio with SP1 and
PAX4/RXR binding sites in eight of nine ovarian cancer gene
promoters. The brain-speciﬁc genes had no proximal ETS
factor binding sites and fewer occurrences of the trio of
binding sites (22% versus 77% in the ovarian cancer genes).
Additional promoter sets supported the importance of ETS
factor binding sites. For example, MLH1 and ITG3BP, which
Figure 4. Co-Regulation of Bidirectional Promoters
(A) The number of bidirectional promoters is graphed for the breast and ovarian cancer genes (solid brown line) and their bidirectional partner genes
(solid black line). All graphs have the same axes: (x) the ranking of genes in the expression cluster according to their distance from the target gene and
(y) the number of bidirectional promoters identified at this distance.
(B) The correlation coefficient between each breast and ovarian cancer gene and its partner was calculated using the expression data in all 79 tissues.
The correlation coefficients are plotted from the largest to smallest values; therefore, the tissue identity may change between plots to accommodate
the ordering scheme.
doi:10.1371/journal.pcbi.0030072.g004
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Systematic Mapping of Bidirectional Promoterswere co-expressed with seven of the ovarian cancer genes,
had two and three consensus ETS factor binding sites within 1
kb of their transcription start sites, respectively. Returning to
the 16,078 co-expression clusters containing 500 genes each,
three clusters with the highest ratio of bidirectional pro-
moters showed a distinct enrichment of the consensus ELK1
motif compared with three co-expression clusters with the
lowest proportion of bidirectional promoters (the compar-
ison returned a p-value ,0.001 in a Chi-square test). The
ELK1 motif was present in an average of 26% of bidirectional
promoters in the enriched dataset and only 6% of bidirec-
tional promoters in the depleted set. Thus, ELK1 binding
sites were not universally present in all bidirectional
promoters.
Discussion
The spliced EST data signiﬁcantly increases the number of
bidirectional promoters that can be identiﬁed in the human
genome and reveals uncharacterized 59 UTRs associated with
some protein-coding genes. These 59 ends may have been
previously overlooked due to a systematic under-representa-
tion of the 59 ends of genes in the curated datasets. The
identiﬁcation of these 59 termini of genes further enables a
precise determination of the position of the associated
promoter. Although the number of genes associated with a
bidirectional promoter seems large, many genes produce
transcripts by selecting from multiple promoters [20]. Given
the extreme diversity in the choice of 59 ends for many
transcripts, bidirectional promoters may support only a
Figure 5. Conserved ETS Factor Binding Sites
(A) Transcription factor-binding sites are shown for the bidirectional promoters of ERBB2, FANCD2, and BRCA2. The vertical arrow points to the binding
site preferred by the ETS factor family member ELK1. The legend indicates the identity of all binding sites.
(B) The sequence level view of these ETS factor binding sites are shown as snapshots from the UCSC Human Genome Browser. Horizontal arrows
indicate the direction of transcription. Position 0 in (A) corresponds to the transcription start site of the cancer genes in (B). The annotation track labeled
‘‘Vertebrate Cons’’ represents the multiple-sequence alignment and conservation track for the eight-way vertebrate genome comparison at the UCSC
Human Genome Browser. The putative ELK1-recognition sequences are boxed. The partner to BRCA2 is not within the range shown.
doi:10.1371/journal.pcbi.0030072.g005
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Systematic Mapping of Bidirectional Promotersminority of transcripts from a single locus. Furthermore, the
large number of bidirectional promoters reported here
represents a portion of an unknown total number of
transcription start sites in the genome.
Relationships among the ten ovarian cancer genes are
supported by their co-expression proﬁles and shared tran-
scription factor-binding sites. For instance, all ten genes and
several co-expressed genes contain ETS-family binding sites
in their promoters. The role of ETS proteins is central to
cancer biology [21]. Although numerous ETS proteins can
bind the same core motif, specialized regulatory instructions
may be dictated through different family members. Thus,
computational approaches cannot conclusively implicate any
particular ETS protein family member. Nevertheless, the
patterns of binding motifs are reminiscent of the collection
of binding sites recognized by the TNF-alpha enhanceosome,
where combinations of binding sites (ETS, NFAT, SP1, and c-
Jun) recruit CBP/p300 and RNA Pol II. Occupancy at these
binding sites varies in response to the environmental cue and
through competition for overlapping binding motifs [22].
A precise list of all genes involved in somatic mutations in
cancer is difﬁcult to deﬁne. Nevertheless, we were able to
show enrichment of bidirectional promoters in cancer-
related gene sets. The presence of shared binding sites
provides a basis for explaining coordinated expression
among these promoters. The evolutionary conservation of
the binding sites argues that they are under selection to fulﬁll
a speciﬁc functional role. The identical placement of these
sites upstream of the promoters implies the mechanism of
action is similar at all three promoters.
Potential for Mis-Regulation of Bidirectional Promoters
In addition to common expression patterns, bidirectional
promoters have the propensity for mis-regulation. Five of the
nine breast and ovarian cancer genes have evidence of
aberrant methylation affecting their expression levels in
somatic tumors (see Table 1). Moreover, methylation of the
MLH1 bidirectional promoter [23] is almost exclusively
responsible for cases of sporadic mismatch-repair deﬁciency
in colon cancer [24]. This gene is located at the center of our
shared expression network. The development of sporadic
cancer is consistent with the loss of important functions of
genes regulated by bidirectional promoters (e.g., genome
stability, transcription, cell cycle control, nucleotide binding,
tumor suppression, or mitochondrial stress response). These
functions extend beyond the role of DNA repair, and are
consistent with a much broader category of functions
involved in the response to DNA damage. Loss of any of
these cellular activities could lead to a neoplastic phenotype.
Additionally, these functions argue that mis-regulation of
bidirectional promoters could extend beyond breast and
ovarian malignancies.
Epigenetic modiﬁcations associated with sporadic breast
and ovarian cancers—such as silencing of bidirectional
promoters—suggest a parallel mechanism by which regula-
tory disturbances could affect similar sets of genes as do
mutations. Methylation could impede the binding of a
protein (such as an ETS factor family member), putatively
affecting the expression of two genes regulated by the
bidirectional promoter. It has been previously shown that
methylation of a bidirectional promoter inhibits expression
of both associated genes [25]. We propose that bidirectional
promoters be explored comprehensively as targets of
aberrant methylation. We have identiﬁed a number of genes
implicated in sporadic breast and ovarian cancers that are
regulated in this manner.
Materials and Methods
EST mapping. The strand information of spliced ESTs was
obtained from the table ‘‘hg17.estOrientInfo’’ at the UCSC Human
Genome Browser (http://www.genome.ucsc.edu), where the direction
of transcription for each EST in the genome is determined based on
consensus intronic splice junctions. Coordinates for both spliced
ESTs, Known Genes, and GenBank mRNA were downloaded from the
UCSC Human Genome Browser. Prior to obtaining the ﬁnal dataset
of bidirectional promoters, our curation process removed question-
able EST pairs (Figure 1), resulting in 5,653 promoter regions
identiﬁed in this analysis. Curation was based on the following steps.
Initial classiﬁcations were made for the intergenic or intragenic
location of the promoter region. Each promoter was subsequently
placed into conﬁdence levels on the basis of supporting ESTs. A
binary decision tree was used for sorting. The tree forked into left
and right branches, representing the intragenic or intergenic
promoters, respectively. Parallel classiﬁcation schemes were imple-
mented along both branches of the tree to assign conﬁdence levels to
the predictions. For instance, ESTs were required to display majority
agreement for the orientation of transcription in the region.
Additional considerations were used to resolve overlapping cis-
transcription units caused by densely packed overlapping genes or
embedded transcripts. Overlapping but antisense transcription units
required comparison with the protein coding gene annotations for
further validation. The predictions were accepted only if there was an
absence of conﬂict with the protein coding gene annotations.
Successive rounds of annotation produced the ﬁnal list of gene pairs.
Seven hundred eight bidirectional promoters fell within introns of
protein coding genes to identify alternative promoters that direct
transcription of both a shorter form of a protein coding gene and a
divergent gene that is antisense to it. These were examined on a case-
by-case basis to ensure their legitimacy. Additional pairs of tran-
scripts were identiﬁed in which one EST and one UCSC Known Gene
are present on each side, accounting for ;159 gene pairs. In total, the
new analysis identiﬁed nearly four times as many bidirectional gene
pairs as were previously published (5,653 versus 1,352).
Expression clustering. GNF Gene Expression Atlas 2 data was
downloaded from the UCSC Human Gene Sorter ([26]; http://www.
genome.ucsc.edu) in gene clusters of the most 500 similarly expressed
genes with a reference gene. The relationships were calculated by
UCSC as a weighted sum of differences in log expression ratios. The
similarity of each gene’s expression proﬁle to all others was extracted
from the table ‘‘hg17.gnfAtlas2Distance’’. For each of the 16,078
genes listed, we obtained the nearest 500 genes, with a threshold score
based on the weighted sum of differences of less than 1.0. The ratio of
bidirectional promoters in each group of 500 was determined by
comparison to our reference list of bidirectional promoters
determined using the EST binary classiﬁcation scheme described in
the section EST mapping and the bidirectional genes identiﬁed in the
UCSC Known genes and GenBank mRNA annotation tracks. For each
cluster of 500 genes, we converted the proportion of bidirectional
promoters in the list into a slope (Figure S2 or Figure 4) for
visualization. The ratio of bidirectional promoters was compared
with monodirectional promoters in the ovarian cancer gene clusters
and brain speciﬁc gene clusters (as in Figure S2), and for pairs of the
ovarian cancer genes that ﬂank the same bidirectional promoter (as
in Figure 4). Bidirectional and monodirectional promoters had a
limit of 1,000 bp from their neighbors and were picked from the same
expression cohorts.
To assess the probability of ﬁnding the same six genes in seven co-
expression clusters, we simulated the situation 10 million times. In
the simulations, the maximum number of genes in common in at least
six of the seven sets was 1, and this occurred in 0.01% of the samples
(i.e., 1 in 10,000).
Multidimensional scaling. The bidirectional promoters that are
associated with the breast and ovarian cancer genes were considered
an afﬁliation network and were transformed into a bipartite graph.
Geodesic distances between genes were computed, and the geodesic
distance matrix was scaled using the metric MDS algorithm in
UCINET 6. The distance between the ovarian cancer genes in Figure
S3 represents their similarity based on the number of shared genes
found in the other ten cancer gene clusters.
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islands assessment, we downloaded tables from the UCSC Human
Genome Browser with the chromosome coordinate to indicate the
position of the Taf250 binding site (hg17.LI Ng val TAF1) and CpG
islands (hg17.cpgIslandExt). These tables contained data for validated
Taf250 binding sites in IMR90 cells. The validation used a condensed
array of sites that were previously observed to be positive in a whole-
genome scan. Coordinates from each dataset were compared with the
bidirectional promoters to ﬁnd those that overlap.
Statistical methods. A Chi-square test of independence veriﬁed the
association of bidirectional promoters and somatic breast cancer
genes with a p-value of 0.01. The same test was used to assess the
association of bidirectional promoters with DNA repair genes and is
described in the main text.
In Figure 3, we observed two intersected, approximate normal
distributions representing the frequency of bidirectional promoters
clustered in the microarray expression proﬁle for 16,078 genes. The
intersection of these two distributions is at ;0.32. Applying Pearson’s
Chi-square test to the 302 DNA repair genes and 546 brain speciﬁc
genes, v2 ¼ 511, df ¼ 1, p , 2.2e-16.
Functional classiﬁcation of genes clustered into coordinately
regulated groups was accomplished using the GOStat server [27].
The software calculates a p-value representing the probability that
the counts could have appeared randomly using a Chi-square or
Fisher’s Exact test depending on the sample size.
The correlation coefﬁcient for the expression of paired genes was
calculated after sorting the tissues according to the similarity of the
expression levels across all 79 tissues. The correlation coefﬁcient was
calculated for subsets of the datapoints, beginning with the ﬁrst ten
tissues and incrementally adding ten tissues each time.
Supporting Information
Figure S1. Veriﬁcation of Bidirectional Promoters Using RIKEN
Transcript Data
The bar graphs show the number of bidirectional promoters that
were conﬁrmed using the independently generated CAGE dataset
from RIKEN. The data are separated into Known Genes, mRNA, and
spliced ESTs for consistency with Figure 1. Blue bars represent CAGE
transcripts for both sides of the bidirectional promoter. Green bars
show the number of promoters with CAGE evidence for only one
ﬂanking transcript. Red bars indicate bidirectional promoters that
are not detectable using the CAGE data. The number of promoters
with support on both sides is printed above the blue bars.
Found at doi:10.1371/journal.pcbi.0030072.sg001 (317 KB PDF).
Figure S2. Bidirectional Promoters versus Monodirectional Pro-
moters
Co-expression clusters were examined for the number of genes
regulated by bidirectional or monodirectional promoters. Bidirec-
tional promoters are graphed in red and monodirectional promoters
in green. (A) depicts the ten breast and ovarian cancer genes. (B)
shows ten brain-speciﬁc genes. All transcription start sites were
within 1 kb of each other. This data was collected from the UCSC
Known Genes only.
Found at doi:10.1371/journal.pcbi.0030072.sg002 (153 KB PDF).
Figure S3. Relationships between Co-Expression Clusters Produced
from MDS
Each node on the graph represents one of the ten breast and ovarian
cancer genes or an aggregate group of genes shared among clusters.
The groups had to contain at least four genes to be included in the
graph. The distance between points is the geodesic distance,
illustrating overall similarity in expression clusters by placing more
related cancer genes closer together. The outside nodes are
associated with a smaller number of shared genes, whereas the
central nodes are associated with a larger number of them. Numbers
were used to label nodes representing groups of shared genes,
whereas names were used to label the cancer reference genes. The
proﬁles containing the MLH1 and ITGB3BP genes lie in the center of
the ﬁgure.
Found at doi:10.1371/journal.pcbi.0030072.sg003 (329 KB PDF).
Table S1. Endometrial Cancer Genes with Bidirectional Promoters
Found at doi:10.1371/journal.pcbi.0030072.st001 (28 KB DOC).
Table S2. Expression Clusters Over- and Under-Represented in
Bidirectional Promoters
Found at doi:10.1371/journal.pcbi.0030072.st002 (69 KB DOC).
Table S3. Bidirectional Promoters in Breast and Ovarian Cancer
Gene Co-Expression Clusters
Found at doi:10.1371/journal.pcbi.0030072.st003 (30 KB DOC).
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